CD44 and breast cancer: In the poorly immunogenic 4T1 breast cancer model, nsPEFs were shown to induce immune memory response by increasing CD4+ effector memory (CD44+CD62L−) and CD8+ central memory (CD44+CD62L+) T lymphocytes that were shown to be highly cytotoxic because of produced IFNγ [9].